Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Davis-Lorton

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 20, 2016
Skin testing and drug challenge outcomes in antibiotic-allergic patients with immediate-type hypersensitivityStephanie L Mawhirt, Luz S Fonacier, Rose Calixte, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 31, 2012
Anaphylaxis in the community setting: determining risk factors for admissionRyan Steele, Marie Camacho-Halili, Barry Rosenthal, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 8, 2018
Skin testing and desensitization outcomes among platinum-sensitive oncology patientsStephanie L Mawhirt, Luz S Fonacier, Rose Calixte, et al.
The Journal of Pediatrics|January 15, 2013
Nanofiltered C1-esterase inhibitor for the acute management and prevention of hereditary angioedema attacks due to C1-inhibitor deficiency in childrenWilliam Lumry, Michael E Manning, David S Hurewitz, et al.
Allergy and Asthma Proceedings|March 17, 2026
Real-world quality of life in patients with hereditary angioedema receiving lanadelumab or other long-term prophylaxisMark Davis-Lorton, Daniel Soteres, William R Lumry, et al.
International Archives of Allergy and Immunology|July 17, 2025
Long-Term Real-World Outcomes in Patients with Hereditary Angioedema Receiving Lanadelumab for 3 or More YearsWilliam R Lumry, Mark Davis-Lorton, Daniel Soteres, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 30, 2011
A multi-center, retrospective review of patch testing for contact dermatitis in allergy practicesMarie Camacho-Halili, Sara Axelrod, Mary Ann Michelis, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|January 25, 2026
Attack rate reductions following berotralstat initiation among US patients with hereditary angioedema in the real-worldMark Davis-Lorton, Raffi Tachdjian, Lorena Lopez-Gonzalez, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 8, 2025
Hereditary Angioedema With Normal C1 Inhibitor: A Quarter Century of Forward Progress and Persisting ObstaclesSandra C Christiansen, Aleena Banerji, Jonathan A Bernstein, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 26, 2014
US Hereditary Angioedema Association Medical Advisory Board 2013 recommendations for the management of hereditary angioedema due to C1 inhibitor deficiencyBruce L Zuraw, Aleena Banerji, Jonathan A Bernstein, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 20, 2016
Skin testing and drug challenge outcomes in antibiotic-allergic patients with immediate-type hypersensitivityStephanie L Mawhirt, Luz S Fonacier, Rose Calixte, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 31, 2012
Anaphylaxis in the community setting: determining risk factors for admissionRyan Steele, Marie Camacho-Halili, Barry Rosenthal, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 8, 2018
Skin testing and desensitization outcomes among platinum-sensitive oncology patientsStephanie L Mawhirt, Luz S Fonacier, Rose Calixte, et al.
The Journal of Pediatrics|January 15, 2013
Nanofiltered C1-esterase inhibitor for the acute management and prevention of hereditary angioedema attacks due to C1-inhibitor deficiency in childrenWilliam Lumry, Michael E Manning, David S Hurewitz, et al.
Allergy and Asthma Proceedings|March 17, 2026
Real-world quality of life in patients with hereditary angioedema receiving lanadelumab or other long-term prophylaxisMark Davis-Lorton, Daniel Soteres, William R Lumry, et al.
International Archives of Allergy and Immunology|July 17, 2025
Long-Term Real-World Outcomes in Patients with Hereditary Angioedema Receiving Lanadelumab for 3 or More YearsWilliam R Lumry, Mark Davis-Lorton, Daniel Soteres, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 30, 2011
A multi-center, retrospective review of patch testing for contact dermatitis in allergy practicesMarie Camacho-Halili, Sara Axelrod, Mary Ann Michelis, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|January 25, 2026
Attack rate reductions following berotralstat initiation among US patients with hereditary angioedema in the real-worldMark Davis-Lorton, Raffi Tachdjian, Lorena Lopez-Gonzalez, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 8, 2025
Hereditary Angioedema With Normal C1 Inhibitor: A Quarter Century of Forward Progress and Persisting ObstaclesSandra C Christiansen, Aleena Banerji, Jonathan A Bernstein, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 26, 2014
US Hereditary Angioedema Association Medical Advisory Board 2013 recommendations for the management of hereditary angioedema due to C1 inhibitor deficiencyBruce L Zuraw, Aleena Banerji, Jonathan A Bernstein, et al.
Pageof 3